The Arab Drug Company (EGX:ADCI)

The Arab Drug Company Ratios and Metrics

Market cap in millions EGP. Fiscal year is July - June.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jan 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Market Capitalization	1,926	1,209	482	401	275	397
Market Cap Growth	133.83%	150.60%	20.27%	45.83%	-30.70%	12.18%
Enterprise Value	2,342	1,638	766	505	302	355
Last Close Price	160.48	97.36	36.05	27.93	17.42	22.93
PE Ratio	8.67	6.08	5.46	5.64	3.61	3.91
Forward PE	-	8.58	8.58	8.58	8.58	8.58
PS Ratio	1.62	1.08	0.61	0.63	0.55	0.74
PB Ratio	3.49	1.95	1.05	1.05	0.81	1.28
P/TBV Ratio	3.49	1.95	1.05	1.05	0.81	1.28
P/FCF Ratio	27.50	-	-	16.49	-	51.48
P/OCF Ratio	10.62	7.36	3.55	4.58	8.37	10.85
EV/Sales Ratio	1.97	1.47	0.98	0.80	0.60	0.66
EV/EBITDA Ratio	0.09	0.06	6.35	5.08	3.01	2.73
EV/EBIT Ratio	6.58	5.25	6.48	5.21	3.32	2.90
EV/FCF Ratio	33.45	-	-	20.77	-	46.03
Debt / Equity Ratio	0.96	0.83	1.13	0.50	0.44	0.07
Debt / EBITDA Ratio	0.02	0.02	4.26	1.91	1.51	0.16
Debt / FCF Ratio	7.55	-	-	7.90	-	2.75
Asset Turnover	0.92	0.91	0.87	1.01	0.99	1.31
Inventory Turnover	2.47	2.31	2.12	1.71	1.61	1.85
Quick Ratio	0.58	0.63	1.01	0.73	0.68	0.80
Current Ratio	1.26	1.52	1.93	2.49	2.31	2.75
Return on Equity (ROE)	51.57%	42.26%	24.43%	22.88%	23.48%	36.32%
Return on Assets (ROA)	17.13%	15.87%	8.13%	9.66%	11.12%	18.67%
Return on Invested Capital (ROIC)	27.21%	26.85%	14.45%	15.43%	19.53%	41.14%
Return on Capital Employed (ROCE)	45.00%	36.00%	15.00%	19.80%	23.10%	39.50%
Earnings Yield	11.53%	18.85%	21.32%	20.64%	27.74%	25.55%
FCF Yield	3.64%	-0.03%	-17.24%	6.07%	-20.74%	1.94%
Dividend Yield	2.63%	4.28%	11.58%	8.06%	13.78%	10.90%
Payout Ratio	24.89%	27.70%	35.11%	45.29%	57.06%	38.31%
Buyback Yield / Dilution	3.98%	-	-	11.45%	2.11%	6.76%
Total Shareholder Return	6.61%	4.28%	11.58%	19.51%	15.89%	17.66%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.